AM-630

AM-630

AM-630
Systematic (IUPAC) name
1-[2-(morpholin-4-yl)ethyl]-2-methyl-3-(4-methoxybenzoyl)-6-iodoindole
Identifiers
CAS Registry Number  N
PubChem CID:
IUPHAR/BPS
ChemSpider  YesY
ChEMBL  YesY
Chemical data
Formula C23H25IN2O3
Molecular mass 504.360 g/mol
 N   

AM-630 (6-Iodopravadoline) is a drug that acts as a potent and selective inverse agonist for the cannabinoid receptor CB2, with a Ki of 32.1nM at CB2 and 165x selectivity over CB1, at which it acted as a weak partial agonist.[1][2] It is used in the study of CB2 mediated responses and has been used to investigate the possible role of CB2 receptors in the brain.[3][4] AM-630 is significant as one of the first indole derived cannabinoid ligands substituted on the 6-position of the indole ring, a position that has subsequently been found to be important in determining affinity and efficacy at both the CB1 and CB2 receptors, and has led to the development of a large number of related derivatives.[5][6][7][8][9]

See also

References

  1. ^
  2. ^
  3. ^
  4. ^
  5. ^
  6. ^ Hongfeng Deng. Design and synthesis of selective cannabinoid receptor ligands: Aminoalkylindole and other heterocyclic analogs. PhD Dissertation, University of Connecticut, 2000.
  7. ^
  8. ^
  9. ^